Homonymous Hemianopia
8
1
5
2
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 25/100
0.0%
0 terminated out of 8 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
100%
2 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (8)
Clinical Trial of Multi-Periscopic Prism Glasses for Hemianopia
Visual Rehabilitation After Occipital Stroke
Feasibility Test of Virtual Reality Obstacle Detection for Low Vision Walking
Reminder-cue Scanning Training for Homonymous Visual Field Loss
Anatomical and Functional Predictions of Blindsight Capabilities in Patients With Lateral Hemianopsia
Homonymous Hemianopia in Childhood
Clinical Trial of Peripheral Prism Glasses for Hemianopia
Assessment of Homonymous Visual Loss and Its Impact on Visual Exploration, Activities of Daily Living (ADL) and Quality of Life (QoL)